Acute myeloid leukaemia · Countries and centres

Cases by country

Cases by country · GLOBOCAN 2022

Site: Leukaemia (all types) (shared total; subtype split not reported). World: 487,294 new cases a year.

#	Country	New cases	Incidence ASR
1	China	81,946	4.5
2	United States of America	63,144	11.2
3	India	49,883	3.6
4	Germany	15,108	7.4
5	Russian Federation	14,495	6.9
6	Indonesia	13,959	5.2
7	Japan	13,572	5.9
8	France (metropolitan)	13,525	10.1
9	Brazil	11,859	4.7
10	Italy	10,799	8.5

GLOBOCAN reports leukaemia as one site; AML is roughly a quarter of cases worldwide.

Show deaths by countryGLOBOCAN's estimated deaths for the same countries, for readers who want them.

Country-level death counts mix every stage, subtype and year of diagnosis, and reflect access to screening and treatment as much as the disease. Survival differs by stage, subtype and year; the cancer page above leads with what can be done.

#	Country	New cases	Deaths
1	China	81,946	50,074
2	United States of America	63,144	23,460
3	India	49,883	36,871
4	Germany	15,108	9,378
5	Russian Federation	14,495	8,224
6	Indonesia	13,959	10,370
7	Japan	13,572	10,066
8	France (metropolitan)	13,525	7,387
9	Brazil	11,859	8,790
10	Italy	10,799	7,197

World: 487,294 new cases and 305,405 deaths a year (GLOBOCAN 2022).

Expert centres

Where the expertise is

Expert centres

99 centres in 34 countries · 4 with a trial for this cancer on record · second-opinion finder →

Choose a region from the globe in the header to mark centres near you.

99 centres


Memorial Sloan Kettering Cancer Center New York · cancer center	United States	NCI comprehensive	1	5,120	95,936	Comprehensive genomic profiling CAR-T cell therapy Digital pathology & AI	#1
National Cancer Institute (NIH) Bethesda, MD · government	United States	none recorded	1	2,852	46,921	TIL therapy TCR-T cell therapy	-
OHSU Knight Cancer Institute Portland, OR · cancer center	United States	NCI comprehensive	1	62	620	Small-molecule kinase inhibitors Functional (ex vivo) drug testing N-of-1 and rapid platform trials	-
The Ohio State University Comprehensive Cancer Center, James Cancer Hospital and Solove Research Institute Columbus, OH · cancer center	United States	NCI comprehensive	1	not matched	-	Small-molecule kinase inhibitors Proton therapy Proton therapy machines: cyclotrons, synchrotrons and single-room systems	-
Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin · hospital	China	none recorded	0	4,969	62,764	CAR-T cell therapy	-
Cancer Institute AP-HP Nord, Université Paris Cité Paris · hospital	France	OECI accredited OECI Comprehensive Cancer Centre	0	2,119	36,693	none recorded	-
Sylvester Comprehensive Cancer Center, University of Miami Miami, FL · cancer center	United States	NCI clinical	0	1,607	15,145	MRD / molecular residual disease testing Proton therapy Proton therapy machines: cyclotrons, synchrotrons and single-room systems	-
Chinese PLA General Hospital Beijing · hospital	China	none recorded	0	1,164	12,024	CAR-T cell therapy CRISPR functional genomics Robotic & minimally invasive surgery PET/CT	-
Centre Léon Bérard Lyon · cancer center	France	none recorded	0	1,061	14,344	Comprehensive genomic profiling Small-molecule kinase inhibitors Immune checkpoint inhibitors	-
Oslo University Hospital, The Norwegian Radium Hospital Oslo · cancer center	Norway	none recorded	0	936	11,600	Targeted alpha therapy Radioligand therapy (beta emitters)TCR-T cell therapy Proton therapy +1	-
Comprehensive Cancer Center Mainfranken, University Hospital Würzburg Würzburg · cancer center	Germany	none recorded	0	817	12,349	CAR-T cell therapy Bispecific antibodies T-cell engagers (bispecific)Radioligand therapy (beta emitters)	-
Guangdong Provincial People's Hospital Guangzhou · hospital	China	none recorded	0	769	8,924	Small-molecule kinase inhibitors Comprehensive genomic profiling Immune checkpoint inhibitors	-
Hospital Universitario 12 de Octubre Madrid · hospital	Spain	none recorded	0	765	13,961	T-cell engagers (bispecific)CAR-T cell therapy MRD / molecular residual disease testing Immune checkpoint inhibitors	-
Chao Family Comprehensive Cancer Center, UC Irvine Orange, CA · cancer center	United States	NCI comprehensive	0	754	12,847	Optical & fluorescence imaging Fluorescence-guided surgery	-
Comprehensive Cancer Center Freiburg (CCCF) Freiburg im Breisgau · cancer center	Germany	none recorded	0	746	6,165	PSMA PET IMRT / IGRT (modern external beam)Allogeneic (off-the-shelf) cell therapy SBRT / SABR (stereotactic radiotherapy)	-

(showing the first 15)

These are the things we can measure; they are not a ranking of quality. Each column is a field on the institution record or a count over what OnCo has linked; a centre that treats many patients with Acute myeloid leukaemia but is thinly recorded here will look small.

Not known: OnCo holds no case-volume or outcome figures for centres, so none are shown. Where a national audit or registry publishes them, the centre's page links to it. Default order: Newsweek rank, then trials for this cancer, then research output.

Seeking a second opinion: ask your oncologist for a referral to a high-volume centre; most accept records and pathology by mail or telehealth. In the US, use the NCI's Find a Cancer Center tool or the nonprofit Cancer Commons, which navigates options for advanced cancers at no cost. The second-opinion finder explains how referral works in your country.

Expert centres named on the types of this cancer

15

15 centres are named on one of the types below rather than on Acute myeloid leukaemia itself. Grouped by the type that holds them; the full table for each sits on that type's page.

Acute myeloid leukaemia in children8

St. Jude Children's Research Hospital Multinational Association of Supportive Care in Cancer Technion, Israel Institute of Technology Cancer Center Clínica Universidad de Navarra / CIMA Cancer Research UK Cambridge Centre / CRUK Cambridge Institute FDA Oncology Center of Excellence IUCT Oncopole (Institut Universitaire du Cancer de Toulouse)Sydney Children's Hospitals Network / Children's Cancer Institute

Acute myeloid leukaemia in older or unfit patients5

European Society for Clinical Nutrition and Metabolism Multinational Association of Supportive Care in Cancer Shaare Zedek Medical Center UZ Leuven / Leuven Cancer Institute Wilmot Cancer Institute, University of Rochester

NPM1-mutated and KMT2A-rearranged acute myeloid leukaemia3

Cancer Center Clínica Universidad de Navarra / CIMA IUCT Oncopole (Institut Universitaire du Cancer de Toulouse)Sydney Children's Hospitals Network / Children's Cancer Institute

IDH1- and IDH2-mutated acute myeloid leukaemia2

Duke Cancer Institute National Cancer Centre Singapore

Secondary and therapy-related acute myeloid leukaemia1

Dana-Farber Brigham Cancer Center